# Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

> **NCT00650936** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1000 (actual)

## Conditions studied

- Atrial Septal Defect

## Interventions

- **DEVICE:** AMPLATZER Septal Occluder

## Key facts

- **NCT ID:** NCT00650936
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00650936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00650936, "Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00650936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*